
Humana Medicaid, marketed as Humana Healthy Horizons, is the Medicaid managed care product line of Humana Inc. (NYSE: HUM), headquartered in Louisville, Kentucky. It operates in 13 states with Georgia and Texas launches planned, serving Medicaid members including dual-eligible populations that pair with Humana's D-SNP Medicare Advantage plans, which grew 18 percent in the 2026 enrollment period.
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Humana Medicaid (Healthy Horizons) | Humana Inc. | Wholly owned |
Humana's Medicaid operations grew out of its broader managed care business in the 1990s and expanded through state contract wins and acquisitions, including the purchase of several regional Medicaid plans. The business was historically a secondary focus behind Medicare Advantage.
The line gained strategic prominence after 2020 as the company consolidated its Medicaid presence under the Healthy Horizons brand in 2021 and began pursuing dual-eligible integration, where members qualify for both Medicaid and Medicare and generate significantly higher combined revenue than either program alone. Florida, Kentucky, Louisiana, Illinois, Ohio, South Carolina, Virginia, Wisconsin, and other states comprise the 13-state footprint as of 2026, with Georgia and Texas launches announced.
The strategy centers on integrating Medicaid managed care with D-SNP Medicare Advantage plans and CenterWell care delivery, positioning Humana to serve the full dual-eligible population in states where it holds both contracts.
What does Humana own?
Humana owns a portfolio of health insurance and healthcare service brands organized under the Humana master brand and the CenterWell service brand. The portfolio includes Humana Medicare (Medicare Advantage plans), Humana Medicaid (managed care in 13 states), Humana Marketplace (ACA exchange plans), Humana Pharmacy (prescription drug services), CenterWell (senior primary care clinics, pharmacy, and home health), Humana Group Plans (employer-sponsored specialty products), and Humana Individual Plans (individual and family coverage).
Is Humana publicly traded?
Yes. Humana Inc. trades on the New York Stock Exchange under ticker symbol HUM. The company has been publicly traded since its corporate restructuring in the 1990s and is a component of major healthcare sector indices. Its market capitalization fluctuates with earnings performance and Medicare Advantage policy developments.
Who founded Humana?
Humana was founded in 1961 by David A. Jones Sr. and Wendell Cherry in Louisville, Kentucky, originally as a nursing home company called Extendicare Inc. The company pivoted to hospital management in the 1970s and then to health insurance in 1993, when it spun off its hospital operations. Jones served as CEO for decades and remained chairman until his retirement.
Where is Humana headquartered?
Humana is headquartered in Louisville, Kentucky, USA. The company has maintained its headquarters in Louisville since its founding in 1961. Humana operates major offices and care delivery facilities across the United States to support its national Medicare Advantage and Medicaid operations.
How many brands does Humana own?
Humana owns 8 major brands and product lines across its health insurance and healthcare services portfolio. These include Humana Medicare, Humana Medicaid, Humana Marketplace, Humana Pharmacy, Humana Healthcare Services, CenterWell, Humana Group Plans, and Humana Individual Plans. The company uses a focused brand strategy rather than a broad multi-brand portfolio.
Who owns Humana?
Humana is publicly owned with shares trading on the NYSE under ticker HUM. Ownership is distributed among institutional investors, mutual funds, and individual shareholders. No single shareholder holds a controlling interest. Major institutional holders include Vanguard Group, BlackRock, and State Street Corporation. The company operates independently without any parent organization.
What is Humana's revenue?
Humana reported FY2025 revenue of $129.7 billion, up from $117.8 billion in FY2024. For FY2026, the company guided to total revenue of at least $160 billion. The Insurance segment generated $124.6 billion in FY2025 revenue, representing 96.3% of consolidated premiums and services revenue. The company's revenue is heavily concentrated in Medicare Advantage, which accounted for 82.6% of Insurance segment premiums in FY2025.
Is Humana involved in any legal proceedings?
Yes. Humana is appealing a federal court's October 2025 decision rejecting its challenge to CMS Star Ratings methodology. The company also faces an ongoing DOJ investigation into Medicare Advantage risk adjustment practices. Additionally, Humana is subject to routine litigation related to claim denials and coverage decisions, which is typical for large health insurers. The company discloses material legal matters in its SEC filings.
Healthy Horizons plans embed social-determinants programs including food benefits, transportation, housing support, and community health workers, core to Humana's health equity reporting. Medicaid plans operate under state-mandated quality incentive programs and NCQA accreditation standards.
Healthy Horizons plans hold NCQA accreditation in their operating states and have received state quality awards. Humana's integrated dual-eligible model has been cited in CMS and Medicaid managed care policy discussions as a care-coordination approach.
Market Exits: Humana has periodically exited Medicaid states where contract economics or strategic fit did not support continued operation, generating member transitions that drew state-level attention.
Dual-Eligible Scrutiny: The company's aggressive D-SNP integration strategy operates amid federal scrutiny of dual-eligible steering and marketing practices across the industry.
Medicaid Rate Environment: Like all Medicaid managed care organizations, Humana faces tight state rate environments that compress margins relative to Medicare economics.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Centene | USA | 1985 | Mass market | United states | All-ages | |
| Cvs Health | United States | 1853 | Mass market | North america | All Genders | |
| Centene | USA | 1993 | Market leader | United states | All-ages | |
| Centene | USA | 1977 | Mass market | United states | All-ages | |
| Molina Healthcare | USA | 1980 | Mass market | United states | All Genders | |
| Elevance Health | USA | 2024 | Mass market | United states | All-ages |
Healthcare PharmaceuticalsOwned by Centene Corporation
Centene Corporation's national Medicare Advantage and prescription drug plan brand, acquired from WellCare Health Plans for $17.3 billion in January 2020.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
American managed care and health insurance company offering medical, dental, pharmacy, and behavioral health plans, operating as a subsidiary of CVS Health Corporation.
Healthcare PharmaceuticalsOwned by Centene Corporation
Centene Corporation's New York State health plan, founded in 1993 by the Catholic bishops of New York and acquired for $3.75 billion in July 2018, serving more than 2.4 million members.
Healthcare PharmaceuticalsOwned by Centene Corporation
Centene Corporation's California health plan brand, founded in 1977 and acquired for approximately $6.8 billion in 2016, serving about three million members through Medi-Cal, Medicare, marketplace, and commercial plans.
InsuranceOwned by Molina Healthcare, Inc.
American managed care brand providing Medicaid, Medicare Advantage, and Marketplace health plans to approximately 5.5 million members in 21 states.
Healthcare PharmaceuticalsOwned by Elevance Health Inc.
Elevance Health's government health plan brand for Medicaid, CHIP, and Medicare in states where Anthem Blue Cross Blue Shield does not operate, rebranded from Amerigroup in January 2024.
Market Positioning: Humana Medicaid (Healthy Horizons) competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Humana Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
Boots is privately owned, unlike Humana Medicaid (Healthy Horizons) which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.
Duane Reade is privately owned, unlike Humana Medicaid (Healthy Horizons) which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Pharmacy Direct is privately owned, unlike Humana Medicaid (Healthy Horizons) which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by EKR Therapeutics, Inc.
Retavase (reteplase) is a prescription thrombolytic medication indicated for acute ST-elevation myocardial infarction. Administered as two 10-unit intravenous bolus injections 30 minutes apart. Currently marketed by Chiesi USA.
Retavase is privately owned, unlike Humana Medicaid (Healthy Horizons) which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by IBSA Institut Biochimique S.A.
IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.
Tirosint is privately owned, unlike Humana Medicaid (Healthy Horizons) which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Walgreens is the largest U.S. pharmacy retail brand, operating roughly 8,000 stores. It went private in August 2025 under Sycamore Partners as a standalone company.
Walgreens is privately owned, unlike Humana Medicaid (Healthy Horizons) which is under a publicly traded parent company.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.